Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on SYNTHOMER PLC. We currently have 19 research reports from 1 professional analysts.
|27Mar17 09:54||RNS||Annual Financial Report|
|06Mar17 07:02||RNS||Acquisition of Perstorp Belgium|
|06Mar17 07:00||RNS||Final Results|
|23Feb17 16:31||RNS||Amendment TR-1 notification|
|08Feb17 16:13||RNS||Holding(s) in Company|
|06Feb17 11:48||RNS||Holding(s) in Company|
|20Jan17 07:00||RNS||Q4 and FY trading update|
Frequency of research reports
Research reports on
N+1 Singer - Morning Song 06-03-2017
06 Mar 17
Abzena (ABZA LN) Abzena inside portfolio progress | Devro (DVO LN) In line Finals and no further surprises | Futura Medical (FUM LN) MED2002 patent filing; market research indicates >$650m OTC potential | Informa (INF LN) Full year results | Itaconix (ITX LN) Primed for growth after strategic repositioning | StatPro Group (SOG LN) Contract win
N+1 Singer - Morning Song 20-01-2017
20 Jan 17
Abzena (ABZA LN) ThioBridge™ licensing deal demonstrates technology leadership | Halfords Group (HFD LN) Positive lead indicators + FX mitigation progress | Midatech Pharma (MTPH LN) FY trading update: revenue ahead of estimates | MySale Group (MYSL LN) Strong progress in H1; positive momentum bodes well for H2 | PCI-PAL (PCIP LN) H1 revenue slightly ahead, CFO stepping down | Raven Russia Ltd (RUS LN) A step forward | SDL (SDL LN) Transformation progressing well | Synthomer (SYNT LN) Positive trading update and forecast upgrade
N+1 Singer - Synthomer - Positive trading update and forecast upgrades
20 Jan 17
Synthomer has released a positive year end trading update, which triggers forecast upgrades this morning. New guidance for FY16 PBT of c.£120m is 12% ahead of previous consensus and c.17% ahead of our previous forecast,. The full year translational benefit from weaker sterling is quantified at £12m and the underlying performance of both regions is ahead of expectations. There is a hint of caution over 2017, given the volatility of the raw material environment, competitive, currency and macro economic factors. More detailed guidance on FY17 will be provided with the prelim results in March. For now, we assume another year of growth and therefore upgrade FY17 PBT by 13% to £125m this morning. We move to BUY from HOLD, lifting our TP to 430p, a 12% increase on our previous TP, in line with the consensus forecast upgrade.
N+1 Singer - MS - Chemicals - International exposure and strong balance sheets underpin sector confidence
27 Jun 16
In the wake of the EU referendum result, our view of the UK chemicals sector remains relatively upbeat. The companies we cover (Croda, Elementis, Scapa, Synthomer, Victrex, Zotefoams) generally have limited domestic exposure and plenty to gain on transactional and/or translational FX exposure. The main beneficiary of FX is Victrex, where as a rule of thumb, we would expect a 10% sterling devaluation to increase Group PBT by 10%, all else being equal. An isolated period of disruption/ contraction in the UK could therefore be comfortably managed by most. Given that some commentators are now also worried about a destabilising effect on the rest of the EU, which could trigger euro weakness, it may make sense to favour those companies with a more balanced international footprint. We therefore highlight Elementis positively, given its high percentage of US sales, but would apply more caution to Synthomer, which has the most European exposure (c.80% of profits last year). Balance sheets are robust and dividend yields high, particularly Elementis and Victrex, which have ongoing special dividend programmes.
28 Apr 16
accesso Technology (ACSO LN) Consistent growth, increasing margins and few risks | Earthport (EPO LN) Solving a $9.3bn+ problem | Gresham Computing (GHT LN) Positive AGM statement | Howden Joinery Group (HWDN LN) Strong trading in recent 8 weeks. Low end f/casts to edge up | James Fisher & Sons (FSJ LN) Trading in line | NCC Group (NCC LN) Strong revenue growth, margins lower | Oxford BioMedica (OXB LN) Final results and portfolio review | Redde (REDD LN) Strong trading continues in H2 | Sepura (SEPU LN) Financing resolution required to unlock potential | Synthomer (SYNT LN) Positive start to 2016 | Victrex (VCT LN) Resolution of US Federal Trade Commission Inquiry
Positive start to 2016
28 Apr 16
Synthomer has released an in line trading update for Q1’16, confirming a positive start to the year. Europe and North America performed better than the strong Q1’15 (volumes down slightly but margins higher and helped by currency). Asia and Rest of World also traded ahead of the prior year. Overall, expectations are unchanged for the full year. An encouraging update.
29 Mar 17
Accsys (AXS): Tricoya consortium structure completed (BUY) | HML Holdings* (HMLH): Acquisition and upgrade (CORP) | Cambridge Cognition* (COG): Old COG with some cool new tricks (CORP) | Transense Technologies* (TRT): Interim results, further payment from GE (CORP) | Hardide* (HDD): Hardide gains Airbus global supplier status approval (CORP) | Omega Diagnostics* (ODX): Regulatory clearance for Malaria test (CORP) | Allergy Therapeutics (AGY): Interims demonstrate strong momentum (BUY)
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.
19 Dec 16
600 GROUP | ACCSYS TECHNOLOGIES | AGGREGATED MICRO POWER HLDGS PLC | ALUMASC GROUP | ANGLO-EASTERN PLANTATIONS | AVINGTRANS PLC | CAPITAL DRILLING LTD | CARCLO | FENNER PLC | FLOWTECH FLUIDPOWER PLC | GLOBAL INVACOM GROUP LTD | GOOCH & HOUSEGO PLC | HARDIDE PLC | HAYWARD TYLER GROUP PLC | IOFINA PLC | M.P.EVANS GROUP | R.E.A. HLDGS PLC | REDT ENERGY PLC | RENOLD | ROBINSON | SOMERO ENTERPRISE INC | SURFACE TRANSFORMS PLC | TRANSENSE TECHNOLOGIES PLC | TRIFAST | ZAMBEEF PRODUCTS
Small Cap Breakfast
03 Mar 17
Venn Life Sciences*( VENN . L) | MediaZest* (MDZ.L) | Legendary Investments (LEG.L) | AFH Financial (AFH.L) | Intercede Group (IGP.L) | Gear4Music Holdings (G4M.L) | Trakm8 Holdings (TRAK.L) | Kodal Minerals (KOD.L) | Applied Graphene Materials (AGM.L) | Velocys (VLS.L)
Panmure - CHEMICALS FLASH - 21-03-2016
21 Mar 16
Full-year results have come in ahead of our expectations at both the top and bottom line, with the period representing an important phase in the evolution of the business. Structural organisation and divisional priorities are further focused on sustaining and growing the specialty materials business and we note a strong signal of intent with regards to receptivity towards increased investment in the business and/or M&A opportunities. Our investment thesis on the business as it presently stands remains, and we note the opportunity to use this as a platform for strategic growth.